2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Thyroid Eye Disease: new trials by email Literature Review of Thyroid Eye Disease trials Research Report on Thyroid Eye Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-VEGF Therapy for Acute Thyroid Eye Disease Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon injection of hyaluronidase (HA) followed by a sub-tenon injection of aflibercept, Sub-tenon injection of hyaluronidase (HA) alone - Thyroid Eye Disease | Phase 2 | Terminated | Massachusetts Eye and Ear Infirmary | 8 | 2020-11-02 | 2026-10-20 |
| Celecoxib for Thyroid Eye Disease Celecoxib, artificial tears - Thyroid Eye Disease | Phase 2 | Terminated | Johns Hopkins University | 7 | 2017-03-05 | 2020-07-31 |
Autoimmune Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Endocrine System Diseases (2) · Exophthalmos (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Goiter (2) · Graves Disease (2) · Hyperthyroidism (2) · Immune System Diseases (2) · Orbital Diseases (2) · Thyroid Diseases (2)
Celecoxib (1) · Lubricant Eye Drops (1) · Single Person (1)
Johns Hopkins University (1) · Massachusetts Eye and Ear Infirmary (1)
United States (2)
Nahoung Grace Lee, MD (1) · Timothy J McCulley, MD (1)